-+ 0.00%
-+ 0.00%
-+ 0.00%

Barclays Maintains Overweight on Celestica, Raises Price Target to $359

Benzinga·11/14/2025 18:51:46
Listen to the news
Barclays analyst George Wang maintains Celestica (NYSE:CLS) with a Overweight and raises the price target from $357 to $359.